OLGA and OLGIM Stage System for Gastric Cancer
The Evaluation of OLGA and OLGIM Stage Systems for Prediction of Gastric Cancer Risk and Interaction With Other Risk Factors According to Lauren's Classification
Sponsor: National Clinical Research Coordination Center, Seoul, Korea
This observational or N/A phase trial investigates Atrophic Gastritis and Intestinal Metaplasia and is currently completed. National Clinical Research Coordination Center, Seoul, Korea leads this study, which shows 12 recorded versions since 2006 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
12 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
May 2023 — Jul 2024 [monthly]
Completed
Status: Unknown Status → Completed
-
Apr 2023 — May 2023 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
▶ Show 7 earlier versions
-
Apr 2021 — Apr 2023 [monthly]
Recruiting
-
Jan 2021 — Apr 2021 [monthly]
Recruiting
-
Oct 2019 — Jan 2021 [monthly]
Recruiting
-
May 2019 — Oct 2019 [monthly]
Recruiting
-
Jun 2018 — May 2019 [monthly]
Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Recruiting
Phase: NA → None
-
Jan 2018 — Apr 2018 [monthly]
Recruiting NA
First recorded
Feb 2006
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Clinical Research Coordination Center, Seoul, Korea
- Seoul National University Bundang Hospital
For direct contact, visit the study record on ClinicalTrials.gov .